KAT2A and acute myeloid leukemia: By using a retroviral-delivered MLL-AF9 model of AML in a conditional Kat2a knockout background, we show that loss of Kat2a depletes AML stem-like cells, imposing a mild delay to disease initiation and severely impairing AML propagation.